U.S. Medical Division

  • About Us
    • History
    • Gunze’s U.S. Medical Division
  • Products
    • Surgical
      • NEOVEIL® Staple Line Reinforcement
      • NEOVEIL® SHEET
    • Advanced Wound Care
      • PELNAC®/THERAGENESIS®
    • Outside The U.S.
      • PRODUCTS OUTSIDE THE U.S.
  • Solutions
    • OEM
    • R&D
  • News
  • Contact
  • About Us
    • History
    • Gunze’s U.S. Medical Division
  • Products
    • Surgical
      • NEOVEIL® Staple Line Reinforcement
      • NEOVEIL® SHEET
    • Advanced Wound Care
      • PELNAC®/THERAGENESIS®
    • Outside The U.S.
      • PRODUCTS OUTSIDE THE U.S.
  • Solutions
    • OEM
    • R&D
  • News
  • Contact
  • About Us
    • History
    • Gunze’s U.S. Medical Division
  • Products
    • Surgical
      • NEOVEIL® Staple Line Reinforcement
      • NEOVEIL® SHEET
    • Advanced Wound Care
      • PELNAC®/THERAGENESIS®
    • Outside The U.S.
      • PRODUCTS OUTSIDE THE U.S.
  • Solutions
    • OEM
    • R&D
  • News
  • Contact

Bioabsorbable technology

with a touch of comfort built-in

Bioabsorbable technology

with a touch of comfort built-in

Bioabsorbable technology

with a touch of comfort built-in

QUALITY PRODUCTS

SOLUTIONS

WHY GUNZE?

Gunze's bioabsorbable medical materials provide comfort and relief post-surgery while enhancing regeneration and healing. Our customers in healthcare have confidence in a proven, trusted brand that has been a source of comfort and strength since 1896.

NEWS

Join Gunze at WHX Miami 2025

Gunze will be exhibiting at the WHX Miami 2025 (formerly FIME) in Miami Beach, Florida. Visit…

Join Gunze at AATS 2025

Gunze will be exhibiting at the American Association for Thoracic Surgery 105th Annual Meeting (AATS 2025)…

Gunze Launches TENALEAF™ Absorbable Adhesion Barrier in Japan
tailored to medical professionals to improve patient clinical outcome

February 24, 2022 Gunze Limited (Headquarters: Osaka, Japan, President: Toshiyasu Saguchi) is pleased to announce that…

Announcing the use of Gunze’s meniscal repair biodegradable scaffolds for a clinical trial to improve the outcome of medial meniscal injury patients at Osaka Medical and Pharmaceutical University

September 16, 2021  (Figure: Biodegradable scaffold for meniscal repair) 1. Background The meniscus is C-shaped cartilage…

Launch of Gunze’s U.S. Medical Division Website

We are excited to announce the launch of our new website!Gunze International U.S.A invites visitors to…

TESTIMONIALS

TISSUE ENGINEERED VASCULAR GRAFT
Angela’s Story

CHRISTOPHER K. BREUER, MD

"Here at Nationwide Children's Hospital, we have found that there may be a way to address and treat congenital heart disease in pediatric patients. The results from our work on Tissue Engineered Vascular Grafts are promising and we look forward to continuing to improve our patients' Quality of Life."

CHRISTOPHER K. BREUER, MD

Gunze International USA, Inc.
390 Fifth Avenue Suite 903
New York, NY 10018
212-354-9060

© GUNZE LIMITED. All rights reserved

  • Terms of Service
  • Privacy Policy
  • Terms of Service
  • Privacy Policy
  • This field is for validation purposes and should be left unchanged.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok